Skip to main content
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.090
-0.060 (-5.22%)
At close: Mar 5, 2026, 4:00 PM EST
1.100
+0.010 (0.92%)
Pre-market: Mar 6, 2026, 7:02 AM EST

Humacyte Revenue

Humacyte had revenue of $753.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $1.57M.

Revenue (ttm)
$1.57M
Revenue Growth
n/a
P/S Ratio
133.91
Revenue / Employee
$7,141
Employees
220
Market Cap
210.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.57M302.00K23.91%
Dec 31, 20211.26M-228.00K-15.29%
Dec 31, 20201.49M-4.70M-75.90%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcturus Therapeutics Holdings 97.60M
Voyager Therapeutics 31.32M
MediWound 20.93M
Crescent Biopharma 10.84M
Prelude Therapeutics 10.50M
Ovid Therapeutics 6.61M
Camp4 Therapeutics 3.80M
Revenue Rankings

HUMA News

More News